Arch Therapeutics, Inc.
SEC CIK 1537561 · ARTH · last insider filing 2023-09-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Norchi Terrence W | Director · See Remarks | filed 2013 - 2023 |
| Hicks Laurence | Director | filed 2021 - 2023 |
| Dhillon Punit | Director | filed 2018 - 2022 |
| Fish Guy L. | Director | filed 2022 - 2022 |
| Sulat James R | Director | filed 2015 - 2021 |
| Dhillon Avtar S | Director | filed 2013 - 2018 |
| Rosenthal Arthur L | Director | filed 2013 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Abrams Michael S | Chief Financial Officer | filed 2021 - 2023 |
| Yrigoyen Dan | Vice President, Sales | filed 2021 - 2022 |
| Davis Richard E | CFO & Treasurer | filed 2014 - 2019 |
| Cotter William M | Chief Operating Officer | filed 2013 - 2014 |
| Barber Alan | Chief Financial Officer | filed 2013 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.